Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NX
NX logo

NX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Quanex Building Products Corp (NX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.970
1 Day change
3.10%
52 Week Range
22.980
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Quanex Building Products Corp (NX) is not a strong buy at the moment for a beginner investor with a long-term focus. The company's financial performance has shown a significant decline in net income and EPS, despite a slight revenue increase. Technical indicators are neutral, and there are no strong trading signals or positive catalysts to justify immediate action. Holding off on investment until clearer positive signals emerge is advisable.

Technical Analysis

The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 50.602, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend. The stock is trading near its pivot level of 17.129, with resistance at 17.95 and support at 16.307.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
8

Positive Catalysts

  • Gross margin increased by 7.52% YoY, indicating some operational efficiency improvements.

Neutral/Negative Catalysts

  • Net income dropped by -72.65% YoY, and EPS fell by -71.88% YoY, reflecting poor profitability. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

In 2026/Q1, revenue increased by 2.26% YoY to $409.089M. However, net income dropped to -$4.071M (-72.65% YoY), and EPS fell to -$0.09 (-71.88% YoY). Gross margin improved to 18.16% (+7.52% YoY), but the overall financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast NX stock price to rise
1 Analyst Rating
Wall Street analysts forecast NX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 17.970
sliders
Low
28
Averages
28
High
28
Current: 17.970
sliders
Low
28
Averages
28
High
28
Benchmark
analyst
Buy
maintain
$30 -> $28
AI Analysis
2025-12-15
Reason
Benchmark
analyst
Price Target
$30 -> $28
AI Analysis
2025-12-15
maintain
Buy
Reason
Benchmark lowered the firm's price target on Quanex to $28 from $30 and keeps a Buy rating on the shares. While FY26 guidance has been pushed to the company's Q1 results release, management's current view is for a flattish year-over-year comparison with the first half likely more challenged than the back half, notes the analyst, who is moving the firm's FY26 and FY27 EPS estimates lower given the uncertain outlook.

People Also Watch